nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ABCB1—colon cancer	0.194	1	CbGaD
Progesterone—SLC22A3—Irinotecan—colon cancer	0.0694	0.129	CbGbCtD
Progesterone—SLC22A3—Vincristine—colon cancer	0.0607	0.113	CbGbCtD
Progesterone—ABCB11—Vincristine—colon cancer	0.0558	0.104	CbGbCtD
Progesterone—ABCC1—Irinotecan—colon cancer	0.0453	0.0844	CbGbCtD
Progesterone—ABCC1—Vincristine—colon cancer	0.0396	0.0738	CbGbCtD
Progesterone—CYP2A6—Fluorouracil—colon cancer	0.0314	0.0586	CbGbCtD
Progesterone—ABCC1—Methotrexate—colon cancer	0.024	0.0447	CbGbCtD
Progesterone—CYP3A7—Irinotecan—colon cancer	0.0224	0.0417	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0224	0.0417	CbGbCtD
Progesterone—CYP3A7—Vincristine—colon cancer	0.0196	0.0365	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0196	0.0365	CbGbCtD
Progesterone—CYP2C9—Capecitabine—colon cancer	0.0182	0.034	CbGbCtD
Progesterone—CYP3A5—Irinotecan—colon cancer	0.0168	0.0313	CbGbCtD
Progesterone—CYP2C8—Fluorouracil—colon cancer	0.0155	0.0289	CbGbCtD
Progesterone—CYP3A5—Vincristine—colon cancer	0.0147	0.0274	CbGbCtD
Progesterone—CYP1A2—Fluorouracil—colon cancer	0.012	0.0224	CbGbCtD
Progesterone—ABCB1—Irinotecan—colon cancer	0.0109	0.0204	CbGbCtD
Progesterone—CYP2C9—Fluorouracil—colon cancer	0.0108	0.0202	CbGbCtD
Progesterone—ABCB1—Vincristine—colon cancer	0.00956	0.0178	CbGbCtD
Progesterone—SLC10A1—bile—colon cancer	0.00832	0.112	CbGeAlD
Progesterone—ABCB11—bile—colon cancer	0.00823	0.111	CbGeAlD
Progesterone—AR—scrotum—colon cancer	0.00704	0.0948	CbGeAlD
Progesterone—CYP3A4—Irinotecan—colon cancer	0.00655	0.0122	CbGbCtD
Progesterone—ABCB1—Methotrexate—colon cancer	0.00579	0.0108	CbGbCtD
Progesterone—CYP3A4—Vincristine—colon cancer	0.00573	0.0107	CbGbCtD
Progesterone—PGR—blood vessel—colon cancer	0.00144	0.0194	CbGeAlD
Progesterone—ESR1—blood vessel—colon cancer	0.00112	0.0151	CbGeAlD
Progesterone—SLC10A1—renal system—colon cancer	0.00111	0.0149	CbGeAlD
Progesterone—CYP17A1—renal system—colon cancer	0.000966	0.013	CbGeAlD
Progesterone—SLC10A1—digestive system—colon cancer	0.000909	0.0123	CbGeAlD
Progesterone—ABCB11—digestive system—colon cancer	0.000899	0.0121	CbGeAlD
Progesterone—SLC22A2—renal system—colon cancer	0.00088	0.0119	CbGeAlD
Progesterone—SLC22A3—embryo—colon cancer	0.000784	0.0106	CbGeAlD
Progesterone—NR3C2—smooth muscle tissue—colon cancer	0.000725	0.00977	CbGeAlD
Progesterone—SLC22A2—digestive system—colon cancer	0.000721	0.00972	CbGeAlD
Progesterone—PGR—epithelium—colon cancer	0.000699	0.00942	CbGeAlD
Progesterone—NR3C2—renal system—colon cancer	0.000698	0.0094	CbGeAlD
Progesterone—SLC10A1—liver—colon cancer	0.000678	0.00913	CbGeAlD
Progesterone—PGR—smooth muscle tissue—colon cancer	0.000674	0.00908	CbGeAlD
Progesterone—ESR1—embryo—colon cancer	0.00067	0.00903	CbGeAlD
Progesterone—ABCB11—liver—colon cancer	0.00067	0.00902	CbGeAlD
Progesterone—CYP3A7—liver—colon cancer	0.000655	0.00883	CbGeAlD
Progesterone—SLC22A1—renal system—colon cancer	0.000621	0.00837	CbGeAlD
Progesterone—SLC22A3—smooth muscle tissue—colon cancer	0.000617	0.00831	CbGeAlD
Progesterone—SIGMAR1—smooth muscle tissue—colon cancer	0.000596	0.00803	CbGeAlD
Progesterone—SLC22A3—renal system—colon cancer	0.000594	0.008	CbGeAlD
Progesterone—CYP17A1—liver—colon cancer	0.00059	0.00795	CbGeAlD
Progesterone—NR3C2—digestive system—colon cancer	0.000572	0.00771	CbGeAlD
Progesterone—CYP1B1—smooth muscle tissue—colon cancer	0.000567	0.00764	CbGeAlD
Progesterone—AR—epithelium—colon cancer	0.000557	0.00751	CbGeAlD
Progesterone—CYP3A7-CYP3A51P—liver—colon cancer	0.000557	0.0075	CbGeAlD
Progesterone—ESR1—epithelium—colon cancer	0.000547	0.00737	CbGeAlD
Progesterone—CYP1B1—renal system—colon cancer	0.000546	0.00735	CbGeAlD
Progesterone—SHBG—bone marrow—colon cancer	0.000545	0.00734	CbGeAlD
Progesterone—CYP2A6—vagina—colon cancer	0.000539	0.00727	CbGeAlD
Progesterone—PGR—lymphoid tissue—colon cancer	0.000539	0.00726	CbGeAlD
Progesterone—AR—smooth muscle tissue—colon cancer	0.000537	0.00723	CbGeAlD
Progesterone—ESR1—smooth muscle tissue—colon cancer	0.000527	0.0071	CbGeAlD
Progesterone—SHBG—vagina—colon cancer	0.000522	0.00703	CbGeAlD
Progesterone—AR—renal system—colon cancer	0.000517	0.00696	CbGeAlD
Progesterone—ESR1—renal system—colon cancer	0.000507	0.00684	CbGeAlD
Progesterone—NR3C2—vagina—colon cancer	0.000505	0.00681	CbGeAlD
Progesterone—NR3C1—embryo—colon cancer	0.000495	0.00666	CbGeAlD
Progesterone—PGR—vagina—colon cancer	0.00047	0.00633	CbGeAlD
Progesterone—CYP2A6—liver—colon cancer	0.000455	0.00613	CbGeAlD
Progesterone—CYP1B1—lymphoid tissue—colon cancer	0.000453	0.00611	CbGeAlD
Progesterone—CYP17A1—lymph node—colon cancer	0.000453	0.0061	CbGeAlD
Progesterone—SLC22A1—vagina—colon cancer	0.00045	0.00606	CbGeAlD
Progesterone—CYP1B1—digestive system—colon cancer	0.000448	0.00603	CbGeAlD
Progesterone—ABCB1—blood vessel—colon cancer	0.000444	0.00598	CbGeAlD
Progesterone—SHBG—liver—colon cancer	0.00044	0.00593	CbGeAlD
Progesterone—SIGMAR1—bone marrow—colon cancer	0.000434	0.00585	CbGeAlD
Progesterone—SLC22A3—vagina—colon cancer	0.00043	0.00579	CbGeAlD
Progesterone—AR—lymphoid tissue—colon cancer	0.000429	0.00578	CbGeAlD
Progesterone—NR3C2—liver—colon cancer	0.000426	0.00575	CbGeAlD
Progesterone—AR—digestive system—colon cancer	0.000424	0.00571	CbGeAlD
Progesterone—ESR1—lymphoid tissue—colon cancer	0.000421	0.00568	CbGeAlD
Progesterone—CYP2C8—renal system—colon cancer	0.000418	0.00563	CbGeAlD
Progesterone—ESR1—digestive system—colon cancer	0.000416	0.00561	CbGeAlD
Progesterone—CYP1A1—epithelium—colon cancer	0.000416	0.0056	CbGeAlD
Progesterone—SIGMAR1—vagina—colon cancer	0.000416	0.0056	CbGeAlD
Progesterone—NR3C1—epithelium—colon cancer	0.000404	0.00544	CbGeAlD
Progesterone—CYP2C19—digestive system—colon cancer	0.000393	0.00529	CbGeAlD
Progesterone—CYP1A2—renal system—colon cancer	0.000391	0.00527	CbGeAlD
Progesterone—NR3C1—smooth muscle tissue—colon cancer	0.000389	0.00524	CbGeAlD
Progesterone—CYP1A1—renal system—colon cancer	0.000386	0.0052	CbGeAlD
Progesterone—SLC22A1—liver—colon cancer	0.00038	0.00512	CbGeAlD
Progesterone—CYP3A5—renal system—colon cancer	0.000377	0.00508	CbGeAlD
Progesterone—AR—vagina—colon cancer	0.000374	0.00504	CbGeAlD
Progesterone—NR3C1—renal system—colon cancer	0.000374	0.00504	CbGeAlD
Progesterone—ESR1—vagina—colon cancer	0.000368	0.00495	CbGeAlD
Progesterone—SLC22A3—liver—colon cancer	0.000363	0.00489	CbGeAlD
Progesterone—ABCC1—vagina—colon cancer	0.000356	0.00479	CbGeAlD
Progesterone—SIGMAR1—liver—colon cancer	0.000351	0.00473	CbGeAlD
Progesterone—CYP2C19—vagina—colon cancer	0.000347	0.00467	CbGeAlD
Progesterone—CYP1B1—liver—colon cancer	0.000333	0.00449	CbGeAlD
Progesterone—NR3C2—lymph node—colon cancer	0.000327	0.00441	CbGeAlD
Progesterone—CYP1A2—digestive system—colon cancer	0.000321	0.00432	CbGeAlD
Progesterone—CYP1A1—digestive system—colon cancer	0.000316	0.00426	CbGeAlD
Progesterone—AR—liver—colon cancer	0.000316	0.00426	CbGeAlD
Progesterone—NR3C1—lymphoid tissue—colon cancer	0.000311	0.00419	CbGeAlD
Progesterone—ESR1—liver—colon cancer	0.00031	0.00418	CbGeAlD
Progesterone—CYP3A5—digestive system—colon cancer	0.000309	0.00417	CbGeAlD
Progesterone—NR3C1—digestive system—colon cancer	0.000307	0.00414	CbGeAlD
Progesterone—CYP2C9—digestive system—colon cancer	0.000305	0.0041	CbGeAlD
Progesterone—PGR—lymph node—colon cancer	0.000304	0.0041	CbGeAlD
Progesterone—CYP2C8—vagina—colon cancer	0.000303	0.00408	CbGeAlD
Progesterone—ABCC1—liver—colon cancer	0.0003	0.00404	CbGeAlD
Progesterone—CYP2C19—liver—colon cancer	0.000293	0.00394	CbGeAlD
Progesterone—CYP3A4—renal system—colon cancer	0.000283	0.00381	CbGeAlD
Progesterone—NR3C1—bone marrow—colon cancer	0.000283	0.00381	CbGeAlD
Progesterone—CYP1A1—vagina—colon cancer	0.000279	0.00377	CbGeAlD
Progesterone—CYP2D6—renal system—colon cancer	0.000279	0.00375	CbGeAlD
Progesterone—SLC22A3—lymph node—colon cancer	0.000278	0.00375	CbGeAlD
Progesterone—CYP3A5—vagina—colon cancer	0.000273	0.00368	CbGeAlD
Progesterone—NR3C1—vagina—colon cancer	0.000271	0.00365	CbGeAlD
Progesterone—SIGMAR1—lymph node—colon cancer	0.000269	0.00362	CbGeAlD
Progesterone—ABCB1—embryo—colon cancer	0.000265	0.00357	CbGeAlD
Progesterone—CYP1B1—lymph node—colon cancer	0.000256	0.00345	CbGeAlD
Progesterone—CYP2C8—liver—colon cancer	0.000255	0.00344	CbGeAlD
Progesterone—AR—lymph node—colon cancer	0.000242	0.00326	CbGeAlD
Progesterone—CYP1A2—liver—colon cancer	0.000239	0.00322	CbGeAlD
Progesterone—ESR1—lymph node—colon cancer	0.000238	0.0032	CbGeAlD
Progesterone—CYP1A1—liver—colon cancer	0.000236	0.00318	CbGeAlD
Progesterone—CYP3A4—digestive system—colon cancer	0.000232	0.00313	CbGeAlD
Progesterone—CYP3A5—liver—colon cancer	0.000231	0.00311	CbGeAlD
Progesterone—ABCC1—lymph node—colon cancer	0.00023	0.0031	CbGeAlD
Progesterone—NR3C1—liver—colon cancer	0.000229	0.00308	CbGeAlD
Progesterone—CYP2D6—digestive system—colon cancer	0.000229	0.00308	CbGeAlD
Progesterone—Drospirenone—PTGS2—colon cancer	0.000228	0.228	CrCbGaD
Progesterone—CYP2C9—liver—colon cancer	0.000227	0.00306	CbGeAlD
Progesterone—Megestrol acetate—ABCB1—colon cancer	0.000222	0.222	CrCbGaD
Progesterone—ABCB1—epithelium—colon cancer	0.000216	0.00291	CbGeAlD
Progesterone—ABCB1—renal system—colon cancer	0.0002	0.0027	CbGeAlD
Progesterone—Infection—Vincristine—colon cancer	0.000189	0.00148	CcSEcCtD
Progesterone—Urinary tract infection—Capecitabine—colon cancer	0.000189	0.00148	CcSEcCtD
Progesterone—Conjunctivitis—Capecitabine—colon cancer	0.000189	0.00148	CcSEcCtD
Progesterone—Convulsion—Fluorouracil—colon cancer	0.000188	0.00148	CcSEcCtD
Progesterone—Osteoarthritis—Methotrexate—colon cancer	0.000187	0.00147	CcSEcCtD
Progesterone—Confusional state—Irinotecan—colon cancer	0.000186	0.00146	CcSEcCtD
Progesterone—Nervous system disorder—Vincristine—colon cancer	0.000186	0.00146	CcSEcCtD
Progesterone—Anaphylactic shock—Irinotecan—colon cancer	0.000185	0.00145	CcSEcCtD
Progesterone—Oedema—Irinotecan—colon cancer	0.000185	0.00145	CcSEcCtD
Progesterone—Myalgia—Fluorouracil—colon cancer	0.000185	0.00145	CcSEcCtD
Progesterone—Chest pain—Fluorouracil—colon cancer	0.000185	0.00145	CcSEcCtD
Progesterone—Infection—Irinotecan—colon cancer	0.000184	0.00144	CcSEcCtD
Progesterone—Hyperhidrosis—Vincristine—colon cancer	0.000183	0.00144	CcSEcCtD
Progesterone—Hepatobiliary disease—Capecitabine—colon cancer	0.000183	0.00144	CcSEcCtD
Progesterone—Discomfort—Fluorouracil—colon cancer	0.000182	0.00143	CcSEcCtD
Progesterone—Shock—Irinotecan—colon cancer	0.000182	0.00143	CcSEcCtD
Progesterone—Nervous system disorder—Irinotecan—colon cancer	0.000181	0.00142	CcSEcCtD
Progesterone—Anorexia—Vincristine—colon cancer	0.000181	0.00142	CcSEcCtD
Progesterone—CYP1A1—lymph node—colon cancer	0.000181	0.00244	CbGeAlD
Progesterone—Irritability—Methotrexate—colon cancer	0.000179	0.00141	CcSEcCtD
Progesterone—Hyperhidrosis—Irinotecan—colon cancer	0.000179	0.0014	CcSEcCtD
Progesterone—Confusional state—Fluorouracil—colon cancer	0.000179	0.0014	CcSEcCtD
Progesterone—Mood swings—Methotrexate—colon cancer	0.000178	0.00139	CcSEcCtD
Progesterone—Hypotension—Vincristine—colon cancer	0.000177	0.00139	CcSEcCtD
Progesterone—Oedema—Fluorouracil—colon cancer	0.000177	0.00139	CcSEcCtD
Progesterone—Anaphylactic shock—Fluorouracil—colon cancer	0.000177	0.00139	CcSEcCtD
Progesterone—Anorexia—Irinotecan—colon cancer	0.000176	0.00138	CcSEcCtD
Progesterone—Infection—Fluorouracil—colon cancer	0.000176	0.00138	CcSEcCtD
Progesterone—NR3C1—lymph node—colon cancer	0.000175	0.00236	CbGeAlD
Progesterone—Haemoglobin—Capecitabine—colon cancer	0.000175	0.00138	CcSEcCtD
Progesterone—Rhinitis—Capecitabine—colon cancer	0.000175	0.00137	CcSEcCtD
Progesterone—Hepatitis—Capecitabine—colon cancer	0.000174	0.00137	CcSEcCtD
Progesterone—Haemorrhage—Capecitabine—colon cancer	0.000174	0.00137	CcSEcCtD
Progesterone—Nervous system disorder—Fluorouracil—colon cancer	0.000174	0.00136	CcSEcCtD
Progesterone—CYP3A4—liver—colon cancer	0.000173	0.00233	CbGeAlD
Progesterone—Liver function test abnormal—Methotrexate—colon cancer	0.000173	0.00136	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000173	0.00136	CcSEcCtD
Progesterone—Pharyngitis—Capecitabine—colon cancer	0.000173	0.00136	CcSEcCtD
Progesterone—Tachycardia—Fluorouracil—colon cancer	0.000173	0.00136	CcSEcCtD
Progesterone—Hypotension—Irinotecan—colon cancer	0.000173	0.00136	CcSEcCtD
Progesterone—Urinary tract disorder—Capecitabine—colon cancer	0.000172	0.00135	CcSEcCtD
Progesterone—Insomnia—Vincristine—colon cancer	0.000172	0.00135	CcSEcCtD
Progesterone—Oedema peripheral—Capecitabine—colon cancer	0.000172	0.00135	CcSEcCtD
Progesterone—Connective tissue disorder—Capecitabine—colon cancer	0.000171	0.00134	CcSEcCtD
Progesterone—Urethral disorder—Capecitabine—colon cancer	0.000171	0.00134	CcSEcCtD
Progesterone—Paraesthesia—Vincristine—colon cancer	0.00017	0.00134	CcSEcCtD
Progesterone—CYP2D6—liver—colon cancer	0.00017	0.00229	CbGeAlD
Progesterone—Breast disorder—Methotrexate—colon cancer	0.000169	0.00133	CcSEcCtD
Progesterone—Anorexia—Fluorouracil—colon cancer	0.000169	0.00133	CcSEcCtD
Progesterone—Visual impairment—Capecitabine—colon cancer	0.000168	0.00132	CcSEcCtD
Progesterone—Insomnia—Irinotecan—colon cancer	0.000167	0.00131	CcSEcCtD
Progesterone—ABCB1—lymphoid tissue—colon cancer	0.000166	0.00224	CbGeAlD
Progesterone—Paraesthesia—Irinotecan—colon cancer	0.000166	0.0013	CcSEcCtD
Progesterone—Hypotension—Fluorouracil—colon cancer	0.000165	0.0013	CcSEcCtD
Progesterone—Decreased appetite—Vincristine—colon cancer	0.000165	0.0013	CcSEcCtD
Progesterone—Dyspnoea—Irinotecan—colon cancer	0.000165	0.00129	CcSEcCtD
Progesterone—Erythema multiforme—Capecitabine—colon cancer	0.000165	0.00129	CcSEcCtD
Progesterone—ABCB1—digestive system—colon cancer	0.000164	0.00221	CbGeAlD
Progesterone—Somnolence—Irinotecan—colon cancer	0.000164	0.00129	CcSEcCtD
Progesterone—Gastrointestinal disorder—Vincristine—colon cancer	0.000164	0.00129	CcSEcCtD
Progesterone—Fatigue—Vincristine—colon cancer	0.000164	0.00129	CcSEcCtD
Progesterone—Eye disorder—Capecitabine—colon cancer	0.000163	0.00128	CcSEcCtD
Progesterone—Dyspepsia—Irinotecan—colon cancer	0.000163	0.00128	CcSEcCtD
Progesterone—Tinnitus—Capecitabine—colon cancer	0.000162	0.00128	CcSEcCtD
Progesterone—Constipation—Vincristine—colon cancer	0.000162	0.00128	CcSEcCtD
Progesterone—Pain—Vincristine—colon cancer	0.000162	0.00128	CcSEcCtD
Progesterone—Asthma—Methotrexate—colon cancer	0.000162	0.00127	CcSEcCtD
Progesterone—Cardiac disorder—Capecitabine—colon cancer	0.000162	0.00127	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000161	0.00127	CcSEcCtD
Progesterone—Decreased appetite—Irinotecan—colon cancer	0.000161	0.00126	CcSEcCtD
Progesterone—Insomnia—Fluorouracil—colon cancer	0.00016	0.00126	CcSEcCtD
Progesterone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00016	0.00125	CcSEcCtD
Progesterone—Fatigue—Irinotecan—colon cancer	0.000159	0.00125	CcSEcCtD
Progesterone—Paraesthesia—Fluorouracil—colon cancer	0.000159	0.00125	CcSEcCtD
Progesterone—Constipation—Irinotecan—colon cancer	0.000158	0.00124	CcSEcCtD
Progesterone—Pain—Irinotecan—colon cancer	0.000158	0.00124	CcSEcCtD
Progesterone—Angiopathy—Capecitabine—colon cancer	0.000158	0.00124	CcSEcCtD
Progesterone—Dyspnoea—Fluorouracil—colon cancer	0.000158	0.00124	CcSEcCtD
Progesterone—Somnolence—Fluorouracil—colon cancer	0.000157	0.00124	CcSEcCtD
Progesterone—Immune system disorder—Capecitabine—colon cancer	0.000157	0.00124	CcSEcCtD
Progesterone—Mediastinal disorder—Capecitabine—colon cancer	0.000157	0.00123	CcSEcCtD
Progesterone—Dyspepsia—Fluorouracil—colon cancer	0.000156	0.00122	CcSEcCtD
Progesterone—Abdominal discomfort—Methotrexate—colon cancer	0.000155	0.00122	CcSEcCtD
Progesterone—Gastrointestinal pain—Vincristine—colon cancer	0.000155	0.00122	CcSEcCtD
Progesterone—Decreased appetite—Fluorouracil—colon cancer	0.000154	0.00121	CcSEcCtD
Progesterone—Alopecia—Capecitabine—colon cancer	0.000154	0.00121	CcSEcCtD
Progesterone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000153	0.0012	CcSEcCtD
Progesterone—Mental disorder—Capecitabine—colon cancer	0.000153	0.0012	CcSEcCtD
Progesterone—Feeling abnormal—Irinotecan—colon cancer	0.000152	0.0012	CcSEcCtD
Progesterone—Malnutrition—Capecitabine—colon cancer	0.000152	0.00119	CcSEcCtD
Progesterone—Erythema—Capecitabine—colon cancer	0.000152	0.00119	CcSEcCtD
Progesterone—ABCB1—bone marrow—colon cancer	0.000152	0.00204	CbGeAlD
Progesterone—Dysuria—Methotrexate—colon cancer	0.000151	0.00119	CcSEcCtD
Progesterone—Pain—Fluorouracil—colon cancer	0.000151	0.00119	CcSEcCtD
Progesterone—Gastrointestinal pain—Irinotecan—colon cancer	0.000151	0.00119	CcSEcCtD
Progesterone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000151	0.00118	CcSEcCtD
Progesterone—Abdominal pain—Vincristine—colon cancer	0.00015	0.00118	CcSEcCtD
Progesterone—Body temperature increased—Vincristine—colon cancer	0.00015	0.00118	CcSEcCtD
Progesterone—Flatulence—Capecitabine—colon cancer	0.000149	0.00117	CcSEcCtD
Progesterone—Back pain—Capecitabine—colon cancer	0.000147	0.00115	CcSEcCtD
Progesterone—Abdominal pain—Irinotecan—colon cancer	0.000146	0.00115	CcSEcCtD
Progesterone—Body temperature increased—Irinotecan—colon cancer	0.000146	0.00115	CcSEcCtD
Progesterone—Feeling abnormal—Fluorouracil—colon cancer	0.000146	0.00115	CcSEcCtD
Progesterone—Muscle spasms—Capecitabine—colon cancer	0.000146	0.00115	CcSEcCtD
Progesterone—Pneumonia—Methotrexate—colon cancer	0.000145	0.00114	CcSEcCtD
Progesterone—ABCB1—vagina—colon cancer	0.000145	0.00196	CbGeAlD
Progesterone—Infestation NOS—Methotrexate—colon cancer	0.000144	0.00113	CcSEcCtD
Progesterone—Infestation—Methotrexate—colon cancer	0.000144	0.00113	CcSEcCtD
Progesterone—Drowsiness—Methotrexate—colon cancer	0.000144	0.00113	CcSEcCtD
Progesterone—Depression—Methotrexate—colon cancer	0.000144	0.00113	CcSEcCtD
Progesterone—Vision blurred—Capecitabine—colon cancer	0.000143	0.00112	CcSEcCtD
Progesterone—Tremor—Capecitabine—colon cancer	0.000142	0.00112	CcSEcCtD
Progesterone—Ill-defined disorder—Capecitabine—colon cancer	0.000141	0.00111	CcSEcCtD
Progesterone—Urticaria—Fluorouracil—colon cancer	0.000141	0.00111	CcSEcCtD
Progesterone—Conjunctivitis—Methotrexate—colon cancer	0.00014	0.0011	CcSEcCtD
Progesterone—Anaemia—Capecitabine—colon cancer	0.00014	0.0011	CcSEcCtD
Progesterone—Body temperature increased—Fluorouracil—colon cancer	0.00014	0.0011	CcSEcCtD
Progesterone—Hypersensitivity—Vincristine—colon cancer	0.00014	0.0011	CcSEcCtD
Progesterone—Spironolactone—ABCB1—colon cancer	0.000138	0.138	CrCbGaD
Progesterone—Malaise—Capecitabine—colon cancer	0.000137	0.00107	CcSEcCtD
Progesterone—Hepatobiliary disease—Methotrexate—colon cancer	0.000137	0.00107	CcSEcCtD
Progesterone—Vertigo—Capecitabine—colon cancer	0.000136	0.00107	CcSEcCtD
Progesterone—Hypersensitivity—Irinotecan—colon cancer	0.000136	0.00107	CcSEcCtD
Progesterone—Asthenia—Vincristine—colon cancer	0.000136	0.00107	CcSEcCtD
Progesterone—Syncope—Capecitabine—colon cancer	0.000136	0.00107	CcSEcCtD
Progesterone—Palpitations—Capecitabine—colon cancer	0.000134	0.00105	CcSEcCtD
Progesterone—Loss of consciousness—Capecitabine—colon cancer	0.000133	0.00105	CcSEcCtD
Progesterone—Asthenia—Irinotecan—colon cancer	0.000133	0.00104	CcSEcCtD
Progesterone—Cough—Capecitabine—colon cancer	0.000132	0.00104	CcSEcCtD
Progesterone—Hypertension—Capecitabine—colon cancer	0.000131	0.00103	CcSEcCtD
Progesterone—Hypersensitivity—Fluorouracil—colon cancer	0.00013	0.00102	CcSEcCtD
Progesterone—Haemoglobin—Methotrexate—colon cancer	0.00013	0.00102	CcSEcCtD
Progesterone—Diarrhoea—Vincristine—colon cancer	0.00013	0.00102	CcSEcCtD
Progesterone—Haemorrhage—Methotrexate—colon cancer	0.00013	0.00102	CcSEcCtD
Progesterone—Hepatitis—Methotrexate—colon cancer	0.00013	0.00102	CcSEcCtD
Progesterone—Myalgia—Capecitabine—colon cancer	0.000129	0.00101	CcSEcCtD
Progesterone—Chest pain—Capecitabine—colon cancer	0.000129	0.00101	CcSEcCtD
Progesterone—Arthralgia—Capecitabine—colon cancer	0.000129	0.00101	CcSEcCtD
Progesterone—Pharyngitis—Methotrexate—colon cancer	0.000129	0.00101	CcSEcCtD
Progesterone—Anxiety—Capecitabine—colon cancer	0.000129	0.00101	CcSEcCtD
Progesterone—Norethindrone—ABCB1—colon cancer	0.000128	0.128	CrCbGaD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000128	0.00101	CcSEcCtD
Progesterone—Urinary tract disorder—Methotrexate—colon cancer	0.000128	0.00101	CcSEcCtD
Progesterone—Discomfort—Capecitabine—colon cancer	0.000128	0.001	CcSEcCtD
Progesterone—Urethral disorder—Methotrexate—colon cancer	0.000127	0.000999	CcSEcCtD
Progesterone—Diarrhoea—Irinotecan—colon cancer	0.000126	0.000994	CcSEcCtD
Progesterone—Dry mouth—Capecitabine—colon cancer	0.000126	0.000992	CcSEcCtD
Progesterone—Dizziness—Vincristine—colon cancer	0.000126	0.000986	CcSEcCtD
Progesterone—Pruritus—Fluorouracil—colon cancer	0.000125	0.000984	CcSEcCtD
Progesterone—Visual impairment—Methotrexate—colon cancer	0.000125	0.000982	CcSEcCtD
Progesterone—Confusional state—Capecitabine—colon cancer	0.000125	0.00098	CcSEcCtD
Progesterone—Oedema—Capecitabine—colon cancer	0.000124	0.000972	CcSEcCtD
Progesterone—Infection—Capecitabine—colon cancer	0.000123	0.000966	CcSEcCtD
Progesterone—Erythema multiforme—Methotrexate—colon cancer	0.000123	0.000963	CcSEcCtD
Progesterone—ABCB1—liver—colon cancer	0.000122	0.00165	CbGeAlD
Progesterone—Dizziness—Irinotecan—colon cancer	0.000122	0.000961	CcSEcCtD
Progesterone—Shock—Capecitabine—colon cancer	0.000122	0.000956	CcSEcCtD
Progesterone—Nervous system disorder—Capecitabine—colon cancer	0.000121	0.000953	CcSEcCtD
Progesterone—Eye disorder—Methotrexate—colon cancer	0.000121	0.000952	CcSEcCtD
Progesterone—Diarrhoea—Fluorouracil—colon cancer	0.000121	0.000952	CcSEcCtD
Progesterone—Tinnitus—Methotrexate—colon cancer	0.000121	0.00095	CcSEcCtD
Progesterone—Tachycardia—Capecitabine—colon cancer	0.000121	0.000949	CcSEcCtD
Progesterone—Vomiting—Vincristine—colon cancer	0.000121	0.000948	CcSEcCtD
Progesterone—Cardiac disorder—Methotrexate—colon cancer	0.00012	0.000945	CcSEcCtD
Progesterone—Skin disorder—Capecitabine—colon cancer	0.00012	0.000944	CcSEcCtD
Progesterone—Prednisolone—ABCB1—colon cancer	0.00012	0.12	CrCbGaD
Progesterone—Rash—Vincristine—colon cancer	0.00012	0.00094	CcSEcCtD
Progesterone—Hyperhidrosis—Capecitabine—colon cancer	0.00012	0.00094	CcSEcCtD
Progesterone—Dermatitis—Vincristine—colon cancer	0.00012	0.00094	CcSEcCtD
Progesterone—Headache—Vincristine—colon cancer	0.000119	0.000934	CcSEcCtD
Progesterone—Anorexia—Capecitabine—colon cancer	0.000118	0.000927	CcSEcCtD
Progesterone—Angiopathy—Methotrexate—colon cancer	0.000118	0.000924	CcSEcCtD
Progesterone—Vomiting—Irinotecan—colon cancer	0.000118	0.000924	CcSEcCtD
Progesterone—Immune system disorder—Methotrexate—colon cancer	0.000117	0.00092	CcSEcCtD
Progesterone—Dizziness—Fluorouracil—colon cancer	0.000117	0.00092	CcSEcCtD
Progesterone—Mediastinal disorder—Methotrexate—colon cancer	0.000117	0.000918	CcSEcCtD
Progesterone—Rash—Irinotecan—colon cancer	0.000117	0.000916	CcSEcCtD
Progesterone—Dermatitis—Irinotecan—colon cancer	0.000116	0.000915	CcSEcCtD
Progesterone—Headache—Irinotecan—colon cancer	0.000116	0.00091	CcSEcCtD
Progesterone—Hypotension—Capecitabine—colon cancer	0.000116	0.000908	CcSEcCtD
Progesterone—Alopecia—Methotrexate—colon cancer	0.000115	0.0009	CcSEcCtD
Progesterone—Mental disorder—Methotrexate—colon cancer	0.000114	0.000892	CcSEcCtD
Progesterone—Malnutrition—Methotrexate—colon cancer	0.000113	0.000887	CcSEcCtD
Progesterone—Erythema—Methotrexate—colon cancer	0.000113	0.000887	CcSEcCtD
Progesterone—Nausea—Vincristine—colon cancer	0.000113	0.000886	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000113	0.000886	CcSEcCtD
Progesterone—Vomiting—Fluorouracil—colon cancer	0.000113	0.000885	CcSEcCtD
Progesterone—Insomnia—Capecitabine—colon cancer	0.000112	0.000879	CcSEcCtD
Progesterone—Rash—Fluorouracil—colon cancer	0.000112	0.000877	CcSEcCtD
Progesterone—Dermatitis—Fluorouracil—colon cancer	0.000112	0.000876	CcSEcCtD
Progesterone—Paraesthesia—Capecitabine—colon cancer	0.000111	0.000873	CcSEcCtD
Progesterone—Headache—Fluorouracil—colon cancer	0.000111	0.000872	CcSEcCtD
Progesterone—Dyspnoea—Capecitabine—colon cancer	0.00011	0.000867	CcSEcCtD
Progesterone—Nausea—Irinotecan—colon cancer	0.00011	0.000863	CcSEcCtD
Progesterone—Back pain—Methotrexate—colon cancer	0.000109	0.000858	CcSEcCtD
Progesterone—Dyspepsia—Capecitabine—colon cancer	0.000109	0.000856	CcSEcCtD
Progesterone—Decreased appetite—Capecitabine—colon cancer	0.000108	0.000845	CcSEcCtD
Progesterone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000107	0.000839	CcSEcCtD
Progesterone—Fatigue—Capecitabine—colon cancer	0.000107	0.000838	CcSEcCtD
Progesterone—Vision blurred—Methotrexate—colon cancer	0.000106	0.000836	CcSEcCtD
Progesterone—Constipation—Capecitabine—colon cancer	0.000106	0.000831	CcSEcCtD
Progesterone—Pain—Capecitabine—colon cancer	0.000106	0.000831	CcSEcCtD
Progesterone—Nausea—Fluorouracil—colon cancer	0.000105	0.000826	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—colon cancer	0.000105	0.000823	CcSEcCtD
Progesterone—Anaemia—Methotrexate—colon cancer	0.000104	0.00082	CcSEcCtD
Progesterone—Feeling abnormal—Capecitabine—colon cancer	0.000102	0.000801	CcSEcCtD
Progesterone—Malaise—Methotrexate—colon cancer	0.000102	0.0008	CcSEcCtD
Progesterone—Vertigo—Methotrexate—colon cancer	0.000101	0.000797	CcSEcCtD
Progesterone—Gastrointestinal pain—Capecitabine—colon cancer	0.000101	0.000795	CcSEcCtD
Progesterone—Cough—Methotrexate—colon cancer	9.85e-05	0.000774	CcSEcCtD
Progesterone—Urticaria—Capecitabine—colon cancer	9.83e-05	0.000772	CcSEcCtD
Progesterone—Abdominal pain—Capecitabine—colon cancer	9.78e-05	0.000768	CcSEcCtD
Progesterone—Body temperature increased—Capecitabine—colon cancer	9.78e-05	0.000768	CcSEcCtD
Progesterone—Convulsion—Methotrexate—colon cancer	9.78e-05	0.000768	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—colon cancer	9.61e-05	0.000755	CcSEcCtD
Progesterone—Chest pain—Methotrexate—colon cancer	9.61e-05	0.000755	CcSEcCtD
Progesterone—Myalgia—Methotrexate—colon cancer	9.61e-05	0.000755	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.54e-05	0.00075	CcSEcCtD
Progesterone—Discomfort—Methotrexate—colon cancer	9.49e-05	0.000746	CcSEcCtD
Progesterone—ABCB1—lymph node—colon cancer	9.39e-05	0.00127	CbGeAlD
Progesterone—Confusional state—Methotrexate—colon cancer	9.29e-05	0.00073	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—colon cancer	9.21e-05	0.000724	CcSEcCtD
Progesterone—Hydrocortisone—ABCB1—colon cancer	9.17e-05	0.0918	CrCbGaD
Progesterone—Infection—Methotrexate—colon cancer	9.15e-05	0.000719	CcSEcCtD
Progesterone—Hypersensitivity—Capecitabine—colon cancer	9.11e-05	0.000716	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—colon cancer	9.03e-05	0.00071	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—colon cancer	8.95e-05	0.000703	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—colon cancer	8.9e-05	0.0007	CcSEcCtD
Progesterone—Asthenia—Capecitabine—colon cancer	8.88e-05	0.000697	CcSEcCtD
Progesterone—Anorexia—Methotrexate—colon cancer	8.78e-05	0.00069	CcSEcCtD
Progesterone—Pruritus—Capecitabine—colon cancer	8.75e-05	0.000688	CcSEcCtD
Progesterone—Hypotension—Methotrexate—colon cancer	8.61e-05	0.000676	CcSEcCtD
Progesterone—Diarrhoea—Capecitabine—colon cancer	8.46e-05	0.000665	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Methotrexate—colon cancer	8.39e-05	0.000659	CcSEcCtD
Progesterone—Insomnia—Methotrexate—colon cancer	8.33e-05	0.000655	CcSEcCtD
Progesterone—Paraesthesia—Methotrexate—colon cancer	8.27e-05	0.00065	CcSEcCtD
Progesterone—Dyspnoea—Methotrexate—colon cancer	8.21e-05	0.000645	CcSEcCtD
Progesterone—Somnolence—Methotrexate—colon cancer	8.19e-05	0.000643	CcSEcCtD
Progesterone—Dizziness—Capecitabine—colon cancer	8.18e-05	0.000643	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—colon cancer	8.11e-05	0.000637	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—colon cancer	8.01e-05	0.000629	CcSEcCtD
Progesterone—Gastrointestinal disorder—Methotrexate—colon cancer	7.95e-05	0.000625	CcSEcCtD
Progesterone—Fatigue—Methotrexate—colon cancer	7.94e-05	0.000624	CcSEcCtD
Progesterone—Pain—Methotrexate—colon cancer	7.88e-05	0.000619	CcSEcCtD
Progesterone—Vomiting—Capecitabine—colon cancer	7.87e-05	0.000618	CcSEcCtD
Progesterone—Rash—Capecitabine—colon cancer	7.8e-05	0.000613	CcSEcCtD
Progesterone—Dermatitis—Capecitabine—colon cancer	7.79e-05	0.000612	CcSEcCtD
Progesterone—Headache—Capecitabine—colon cancer	7.75e-05	0.000609	CcSEcCtD
Progesterone—Feeling abnormal—Methotrexate—colon cancer	7.59e-05	0.000596	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—colon cancer	7.53e-05	0.000592	CcSEcCtD
Progesterone—Nausea—Capecitabine—colon cancer	7.35e-05	0.000577	CcSEcCtD
Progesterone—Urticaria—Methotrexate—colon cancer	7.32e-05	0.000575	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—colon cancer	7.28e-05	0.000572	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—colon cancer	7.28e-05	0.000572	CcSEcCtD
Progesterone—Testosterone—ABCB1—colon cancer	7.07e-05	0.0707	CrCbGaD
Progesterone—Hypersensitivity—Methotrexate—colon cancer	6.79e-05	0.000533	CcSEcCtD
Progesterone—Asthenia—Methotrexate—colon cancer	6.61e-05	0.000519	CcSEcCtD
Progesterone—Pruritus—Methotrexate—colon cancer	6.52e-05	0.000512	CcSEcCtD
Progesterone—Diarrhoea—Methotrexate—colon cancer	6.3e-05	0.000495	CcSEcCtD
Progesterone—Dizziness—Methotrexate—colon cancer	6.09e-05	0.000479	CcSEcCtD
Progesterone—Vomiting—Methotrexate—colon cancer	5.86e-05	0.00046	CcSEcCtD
Progesterone—Rash—Methotrexate—colon cancer	5.81e-05	0.000456	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—colon cancer	5.8e-05	0.000456	CcSEcCtD
Progesterone—Headache—Methotrexate—colon cancer	5.77e-05	0.000453	CcSEcCtD
Progesterone—Nausea—Methotrexate—colon cancer	5.47e-05	0.00043	CcSEcCtD
Progesterone—SLC22A2—Neuronal System—HRAS—colon cancer	1.49e-05	0.000222	CbGpPWpGaD
Progesterone—AR—Gene Expression—PPARG—colon cancer	1.44e-05	0.000215	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—EP300—colon cancer	1.42e-05	0.000212	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.41e-05	0.000211	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.4e-05	0.000209	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.4e-05	0.000209	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.39e-05	0.000207	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FGFR3—colon cancer	1.39e-05	0.000207	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—HRAS—colon cancer	1.39e-05	0.000207	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ABCB1—colon cancer	1.38e-05	0.000206	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.37e-05	0.000205	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.37e-05	0.000204	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—TYMS—colon cancer	1.36e-05	0.000202	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ABCB1—colon cancer	1.34e-05	0.000199	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PPARG—colon cancer	1.34e-05	0.000199	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—MYC—colon cancer	1.32e-05	0.000196	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—TYMS—colon cancer	1.31e-05	0.000196	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	1.3e-05	0.000193	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.3e-05	0.000193	CbGpPWpGaD
Progesterone—ABCC1—Disease—FGFR3—colon cancer	1.3e-05	0.000193	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.29e-05	0.000192	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PPARG—colon cancer	1.28e-05	0.000191	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—APC—colon cancer	1.28e-05	0.00019	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—colon cancer	1.25e-05	0.000187	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—AKT1—colon cancer	1.23e-05	0.000183	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ABCB1—colon cancer	1.21e-05	0.00018	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ABCB1—colon cancer	1.2e-05	0.000179	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—BRAF—colon cancer	1.2e-05	0.000179	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.19e-05	0.000178	CbGpPWpGaD
Progesterone—ABCC1—Disease—APC—colon cancer	1.19e-05	0.000177	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—TYMS—colon cancer	1.18e-05	0.000177	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—TYMS—colon cancer	1.18e-05	0.000176	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.18e-05	0.000176	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.15e-05	0.000172	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ABCB1—colon cancer	1.12e-05	0.000167	CbGpPWpGaD
Progesterone—ABCC1—Disease—BRAF—colon cancer	1.12e-05	0.000167	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—PPARG—colon cancer	1.11e-05	0.000166	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ABCB1—colon cancer	1.11e-05	0.000165	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—TYMS—colon cancer	1.1e-05	0.000164	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—PPARG—colon cancer	1.1e-05	0.000163	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FGFR3—colon cancer	1.09e-05	0.000162	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—TYMS—colon cancer	1.09e-05	0.000162	CbGpPWpGaD
Progesterone—PGR—Gene Expression—MYC—colon cancer	1.08e-05	0.000161	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.05e-05	0.000157	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PIK3CA—colon cancer	1.05e-05	0.000157	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—colon cancer	1.05e-05	0.000157	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.05e-05	0.000156	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—EP300—colon cancer	1.04e-05	0.000156	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.01e-05	0.000151	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.01e-05	0.000151	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—colon cancer	1.01e-05	0.00015	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—APC—colon cancer	1e-05	0.000149	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—NRAS—colon cancer	1e-05	0.000149	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	9.73e-06	0.000145	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PPARG—colon cancer	9.62e-06	0.000143	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.6e-06	0.000143	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—BRAF—colon cancer	9.4e-06	0.00014	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PPARG—colon cancer	9.3e-06	0.000139	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.28e-06	0.000138	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—colon cancer	9.11e-06	0.000136	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—colon cancer	9.03e-06	0.000135	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CASP3—colon cancer	9e-06	0.000134	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCND1—colon cancer	8.76e-06	0.000131	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—EP300—colon cancer	8.74e-06	0.00013	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ABCB1—colon cancer	8.72e-06	0.00013	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—PIK3CA—colon cancer	8.71e-06	0.00013	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CTNNB1—colon cancer	8.67e-06	0.000129	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—KRAS—colon cancer	8.61e-06	0.000128	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AKT1—colon cancer	8.59e-06	0.000128	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—TYMS—colon cancer	8.56e-06	0.000128	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CDKN1A—colon cancer	8.47e-06	0.000126	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.42e-06	0.000125	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PPARG—colon cancer	8.39e-06	0.000125	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—EP300—colon cancer	8.38e-06	0.000125	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PPARG—colon cancer	8.38e-06	0.000125	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.28e-06	0.000123	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ABCB1—colon cancer	8.23e-06	0.000123	CbGpPWpGaD
Progesterone—AR—Gene Expression—MYC—colon cancer	8.23e-06	0.000123	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.2e-06	0.000122	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGFR3—colon cancer	8.16e-06	0.000122	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TYMS—colon cancer	8.09e-06	0.000121	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—colon cancer	8.08e-06	0.000121	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EP300—colon cancer	8.06e-06	0.00012	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PIK3CA—colon cancer	7.91e-06	0.000118	CbGpPWpGaD
Progesterone—ABCC1—Disease—CDKN1A—colon cancer	7.9e-06	0.000118	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SRC—colon cancer	7.84e-06	0.000117	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PPARG—colon cancer	7.81e-06	0.000116	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PIK3CA—colon cancer	7.72e-06	0.000115	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.72e-06	0.000115	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PPARG—colon cancer	7.69e-06	0.000115	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—colon cancer	7.63e-06	0.000114	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—colon cancer	7.57e-06	0.000113	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.55e-06	0.000113	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ABCB1—colon cancer	7.55e-06	0.000113	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—colon cancer	7.54e-06	0.000112	CbGpPWpGaD
Progesterone—ABCC1—Disease—EP300—colon cancer	7.51e-06	0.000112	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APC—colon cancer	7.49e-06	0.000112	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—colon cancer	7.49e-06	0.000112	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TYMS—colon cancer	7.41e-06	0.000111	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—colon cancer	7.32e-06	0.000109	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—colon cancer	7.31e-06	0.000109	CbGpPWpGaD
Progesterone—ABCC1—Disease—SRC—colon cancer	7.31e-06	0.000109	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—colon cancer	7.11e-06	0.000106	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—colon cancer	7.05e-06	0.000105	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—colon cancer	7.04e-06	0.000105	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—colon cancer	7.03e-06	0.000105	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MYC—colon cancer	7.02e-06	0.000105	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TGFB1—colon cancer	7.01e-06	0.000104	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.89e-06	0.000103	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—colon cancer	6.87e-06	0.000102	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—colon cancer	6.86e-06	0.000102	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—colon cancer	6.79e-06	0.000101	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ABCB1—colon cancer	6.74e-06	0.0001	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDKN1A—colon cancer	6.64e-06	9.89e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TYMS—colon cancer	6.62e-06	9.87e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—colon cancer	6.6e-06	9.84e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—colon cancer	6.59e-06	9.82e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—MYC—colon cancer	6.55e-06	9.76e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—TGFB1—colon cancer	6.53e-06	9.74e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—colon cancer	6.49e-06	9.68e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PIK3CA—colon cancer	6.46e-06	9.64e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TYMS—colon cancer	6.46e-06	9.63e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—colon cancer	6.46e-06	9.63e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.45e-06	9.62e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—colon cancer	6.4e-06	9.55e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—MYC—colon cancer	6.34e-06	9.45e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EP300—colon cancer	6.31e-06	9.41e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—colon cancer	6.3e-06	9.4e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—EP300—colon cancer	6.29e-06	9.38e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.28e-06	9.36e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—MYC—colon cancer	6.24e-06	9.31e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.23e-06	9.28e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ABCB1—colon cancer	6.2e-06	9.24e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PIK3CA—colon cancer	6.2e-06	9.24e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ABCB1—colon cancer	6.14e-06	9.16e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—colon cancer	6.14e-06	9.16e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SRC—colon cancer	6.14e-06	9.15e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TYMS—colon cancer	6.09e-06	9.07e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—EP300—colon cancer	6.09e-06	9.07e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—colon cancer	6.06e-06	9.04e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—colon cancer	6.05e-06	9.02e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—colon cancer	6.05e-06	9.02e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TYMS—colon cancer	6.03e-06	9e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—colon cancer	5.98e-06	8.91e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PIK3CA—colon cancer	5.96e-06	8.89e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—colon cancer	5.91e-06	8.81e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—colon cancer	5.77e-06	8.6e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—colon cancer	5.73e-06	8.54e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—colon cancer	5.71e-06	8.51e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.71e-06	8.51e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—PIK3CA—colon cancer	5.56e-06	8.29e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—colon cancer	5.52e-06	8.22e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MYC—colon cancer	5.5e-06	8.2e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—EP300—colon cancer	5.49e-06	8.18e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TGFB1—colon cancer	5.49e-06	8.18e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—EP300—colon cancer	5.48e-06	8.17e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—colon cancer	5.38e-06	8.02e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.37e-06	8e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—colon cancer	5.28e-06	7.87e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—colon cancer	5.28e-06	7.87e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—colon cancer	5.25e-06	7.83e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ABCB1—colon cancer	5.25e-06	7.83e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TYMS—colon cancer	5.16e-06	7.69e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—colon cancer	5.14e-06	7.67e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—colon cancer	5.14e-06	7.66e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—EP300—colon cancer	5.11e-06	7.61e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.09e-06	7.6e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—colon cancer	5.09e-06	7.59e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—colon cancer	5.08e-06	7.58e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—colon cancer	5.06e-06	7.55e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—EP300—colon cancer	5.03e-06	7.5e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDKN1A—colon cancer	4.97e-06	7.41e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—colon cancer	4.87e-06	7.26e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—colon cancer	4.77e-06	7.11e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EP300—colon cancer	4.73e-06	7.05e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—colon cancer	4.69e-06	6.99e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PIK3CA—colon cancer	4.67e-06	6.96e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PIK3CA—colon cancer	4.65e-06	6.94e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.65e-06	6.93e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SRC—colon cancer	4.6e-06	6.86e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—colon cancer	4.58e-06	6.82e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—colon cancer	4.54e-06	6.77e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—colon cancer	4.52e-06	6.74e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—colon cancer	4.51e-06	6.72e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PIK3CA—colon cancer	4.5e-06	6.71e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—colon cancer	4.48e-06	6.68e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—colon cancer	4.43e-06	6.6e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—colon cancer	4.4e-06	6.56e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—colon cancer	4.33e-06	6.46e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—colon cancer	4.32e-06	6.44e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—colon cancer	4.31e-06	6.43e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—colon cancer	4.27e-06	6.37e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—colon cancer	4.13e-06	6.16e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MYC—colon cancer	4.12e-06	6.15e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TGFB1—colon cancer	4.11e-06	6.13e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PIK3CA—colon cancer	4.06e-06	6.05e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PIK3CA—colon cancer	4.05e-06	6.04e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ABCB1—colon cancer	4.05e-06	6.04e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—colon cancer	4.03e-06	6.01e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TYMS—colon cancer	3.98e-06	5.93e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.97e-06	5.92e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—EP300—colon cancer	3.97e-06	5.91e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—colon cancer	3.82e-06	5.69e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—colon cancer	3.81e-06	5.68e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—colon cancer	3.8e-06	5.67e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PIK3CA—colon cancer	3.78e-06	5.63e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—EP300—colon cancer	3.75e-06	5.59e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PIK3CA—colon cancer	3.72e-06	5.55e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—colon cancer	3.69e-06	5.5e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—colon cancer	3.68e-06	5.48e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—colon cancer	3.65e-06	5.45e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—colon cancer	3.6e-06	5.37e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PIK3CA—colon cancer	3.5e-06	5.22e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—EP300—colon cancer	3.44e-06	5.12e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—colon cancer	3.39e-06	5.06e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—colon cancer	3.39e-06	5.05e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—colon cancer	3.36e-06	5.01e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—colon cancer	3.32e-06	4.94e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—colon cancer	3.31e-06	4.94e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—colon cancer	3.24e-06	4.83e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—colon cancer	3.09e-06	4.6e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—EP300—colon cancer	3.07e-06	4.57e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—colon cancer	3.04e-06	4.53e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—EP300—colon cancer	2.99e-06	4.46e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PIK3CA—colon cancer	2.93e-06	4.38e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—colon cancer	2.87e-06	4.28e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—colon cancer	2.86e-06	4.26e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—EP300—colon cancer	2.82e-06	4.21e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—colon cancer	2.82e-06	4.2e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—EP300—colon cancer	2.8e-06	4.17e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PIK3CA—colon cancer	2.77e-06	4.13e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PIK3CA—colon cancer	2.54e-06	3.79e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—colon cancer	2.4e-06	3.57e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—EP300—colon cancer	2.39e-06	3.56e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PIK3CA—colon cancer	2.27e-06	3.38e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—colon cancer	2.26e-06	3.38e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—colon cancer	2.22e-06	3.31e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PIK3CA—colon cancer	2.21e-06	3.3e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PIK3CA—colon cancer	2.09e-06	3.11e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—colon cancer	2.08e-06	3.1e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PIK3CA—colon cancer	2.07e-06	3.08e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—colon cancer	1.85e-06	2.76e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—EP300—colon cancer	1.84e-06	2.75e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—colon cancer	1.81e-06	2.7e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PIK3CA—colon cancer	1.77e-06	2.64e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—colon cancer	1.7e-06	2.54e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—colon cancer	1.69e-06	2.52e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—colon cancer	1.44e-06	2.15e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PIK3CA—colon cancer	1.36e-06	2.03e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—colon cancer	1.11e-06	1.66e-05	CbGpPWpGaD
